Gnosis by Lesaffre
Biotechnology company making fermentation-derived actives, probiotics and nutritional yeasts.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Gnosis by Lesaffre is a biotechnology company specializing in fermentation-derived active ingredients, probiotics, and nutritional yeasts. Originally founded in 1989 as Gnosis S.p.A. in Desio, Italy (near Milan), the company was fully acquired by Lesaffre in 2018. Gnosis operates GMP manufacturing sites in Sant Antonino, Switzerland and Pisticci, Italy, with commercial offices in the US and China. The parent company Lesaffre is one of the world's largest yeast producers with EUR 2 billion in annual revenue. Key ingredients include vitaMK7 (naturally fermented vitamin K2 as MK-7), Quatrefolic (5-MTHF folate), and LifeinU L.rhamnosus GG probiotic. Gnosis has a joint venture with ADM (Red Star Yeast) in the United States.
Certifications
Certification verification in progress. International supplier records require regional database lookups (EudraGMDP, Health Canada NHP, FSSC public register, JHFA directory). See our methodology.
Capabilities
- PRODUCT TYPES
- Fermentation-Derived Active Ingredients · vitaMK7 (Vitamin K2 as MK-7) · Quatrefolic (5-MTHF Folate) · Probiotics (LifeinU L.rhamnosus GG) · Nutritional Yeasts · S-Adenosyl-L-Methionine (SAMe)
- CAPABILITIES
- Branded or patented ingredients · Clinical research or study support · Fermentation or culture-grown ingredients · US production · North American distribution or office
Sources
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- R&D and offices in Desio, Italy; manufacturing in Switzerland and Italy
- Acquired by Lesaffre (French parent) in 2018. Corporate structure is complex
- GMP manufacturing sites claimed but not independently verified from public directories
- US commercial office exists but specific location not confirmed
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between Gnosis by Lesaffre and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Interested in Gnosis by Lesaffre?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.